While several mechanisms of acquired EGFR-TKI resistance have been uncovered by analyzing tumor specimens obtained at disease progression [17,18,29], the factors influencing the initial response and causing primary resistance to TKIs have been less studied. The gene discussed is EGFR; the disease is neoplasm.